Find the right Medicare plan for 2025 — compare coverage and costs in minutes.

Compare Medicare Plans →
Medicare News MedCity News

Neuro Startup Tortugas Unveils $106M and a Pipeline of Drugs for the Brain

Tortugas Neurosciences’ two lead programs are in-licensed oral small molecules in development for schizophrenia and tinnitus. The startup is led by veterans of Sage Therapeutics, a neuroscience biotech that was acquired last year. The post Neuro Startup Tortugas Unveils $106M and a Pipeline of Drugs for the Brain appeared first on MedCity News .

Read full article →
Medicare News MedCity News

The Next Era of Payment Integrity: Earlier Clinical Validation, True Transparency

By using AI-powered intelligence to shift clinical and coding validation earlier in the healthcare continuum, and unlocking upstream clinical data to inform downstream payment workflows, organizations can proactively prevent errors, reduce downstream churn and friction, and support more predictable, accurate, and timely payments. The post The Next Era of Payment Integrity: Earlier Clinical Validation, True Transparency appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Revenue Isn’t the Signal: What Early-Stage Health Tech Investors Should Be Watching Instead

What matters just as much — if not more — is everything around that number: how customers adopt the product, how sales actually happen, and whether the company is building something that can scale inside a complex, regulated system. The post Revenue Isn’t the Signal: What Early-Stage Health Tech Investors Should Be Watching Instead appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Stopping Patient Attrition Before it Starts: A Proactive Approach to Healthcare Marketing

When patients disengage, preventive care is missed, chronic conditions worsen, care shifts to higher-cost settings such as the emergency department and urgent care, and patients fragment across systems, reducing continuity. The post Stopping Patient Attrition Before it Starts: A Proactive Approach to Healthcare Marketing appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs In

Himanshu Shah, an activist investor and large shareholder of Novavax, whose stock has plummeted over the years, believes the company should cut costs more aggressively, reduce the size of its board, and do more to prop up its financial performance. But are the criticisms valid? The post Is Shah Capital’s Criticism of Novavax Fair? A Wall Street Analyst Weighs In appeared first on MedCity News .

Read full article →
Medicare News MedCity News

Obsidian, Galera Merger Comes With $350M Infusion for Cancer Drug Trials

Obsidian Therapeutics aims to show its TIL cell therapy has advantages over an Iovance Biotherapeutics TIL therapy marketed for treating melanoma. Obsidian’s merger with Galera Therapeutics will give it a public listing and a private placement to support clinical development of the combined company’s cancer drug pipeline. The post Obsidian, Galera Merger Comes With $350M Infusion for Cancer Drug Trials appeared first on MedCity News .

Read full article →